0001209191-17-047468.txt : 20170803
0001209191-17-047468.hdr.sgml : 20170803
20170803174239
ACCESSION NUMBER: 0001209191-17-047468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170801
FILED AS OF DATE: 20170803
DATE AS OF CHANGE: 20170803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURDOCK TERRY L
CENTRAL INDEX KEY: 0001274071
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 171006251
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-01
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001274071
MURDOCK TERRY L
79 T.W. ALEXANDER DRIVE
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
SVP of Development Operations
Stock option (right to buy)
13.51
2017-08-01
4
A
0
100000
0.00
A
2027-08-01
Common Stock
100000
100000
D
The shares underlying this option will vest as to 25% of the shares on August 1, 2018, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
/s/ Caroline G. Gammill, attorney-in-fact
2017-08-03